{"transactions":[{"id":1423,"issuer":{"id":1161,"kind":"organization","name":"Camp4 Therapeutics Corp","symbol":"CAMP"},"owners":[{"id":1162,"kind":"person","name":"Gold Kelly","position":1,"cik":"0002033333","reported_name":"Gold Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-02T23:50:12.000Z","date":"2026-08-31","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.96,"value":39600.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares reported herein were purchased in the open market in multiple transactions at prices ranging from $3.88 to $4.00, inclusive. The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to CAMP4 Therapeutics Corporation, any security holder of CAMP4, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares reported herein are held in a brokerage account in the name of David Gold, the Reporting Person's spouse. The Reporting Person does not exercise investment control over this account. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001628280-26-060234","document":"wk-form4_1788393010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033333/000162828026060234/wk-form4_1788393010.xml","form_type":"4"}},{"id":696003,"issuer":{"id":1161,"kind":"organization","name":"Camp4 Therapeutics Corp","symbol":"CAMP"},"owners":[{"id":1162,"kind":"person","name":"Gold Kelly","position":1,"cik":"0002033333","reported_name":"Gold Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-05T21:08:18.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":6551,"price":1.65,"value":10809.15,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 3, 2026, the reporting person acquired shares in the second closing of a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement, dated as of September 9, 2025, as amended on August 3, 2026, by and among the Issuer and certain institutional investors and certain directors, employees, and consultants, at a purchase price of $1.65 per share."}],"balance_after":74428,"source":{"system":"sec-edgar","filing":"0001628280-26-053511","document":"wk-form4_1785964091.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033333/000162828026053511/wk-form4_1785964091.xml","form_type":"4"}},{"id":721579,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":1162,"kind":"person","name":"Gold Kelly","position":1,"cik":"0002033333","reported_name":"Gold Kelly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-01T20:20:10.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the one-year anniversary of the grant date, subject to the Reporting Person continuing to provide services through such date."}],"balance_after":110000,"derivative":{"exercise_price":4.085,"expiration_date":"2036-07-01","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001501697-26-000064","document":"wk-form4_1782937206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033333/000150169726000064/wk-form4_1782937206.xml","form_type":"4"}},{"id":817109,"issuer":{"id":1161,"kind":"organization","name":"Camp4 Therapeutics Corp","symbol":"CAMP"},"owners":[{"id":1162,"kind":"person","name":"Gold Kelly","position":1,"cik":"0002033333","reported_name":"Gold Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T20:47:04.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":215000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest in equal monthly installments over a period of four years commencing from the date of grant."}],"balance_after":215000,"derivative":{"exercise_price":4.46,"expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0002033333-26-000002","document":"wk-form4_1775249221.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033333/000203333326000002/wk-form4_1775249221.xml","form_type":"4"}},{"id":961237,"issuer":{"id":1161,"kind":"organization","name":"Camp4 Therapeutics Corp","symbol":"CAMP"},"owners":[{"id":1162,"kind":"person","name":"Gold Kelly","position":1,"cik":"0002033333","reported_name":"Gold Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-22T22:41:33.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option has a vesting start date of December 1, 2025 and vests as to one third (33.33%) of the shares subject to the option on the first anniversary of the vesting start date and as to the remaining shares in equal monthly installments over 24 months thereafter, subject to continued service."}],"balance_after":190000,"derivative":{"exercise_price":6.01,"expiration_date":"2035-12-10","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0002033333-25-000005","document":"wk-form4_1766443290.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033333/000203333325000005/wk-form4_1766443290.xml","form_type":"4"}},{"id":1043057,"issuer":{"id":1161,"kind":"organization","name":"Camp4 Therapeutics Corp","symbol":"CAMP"},"owners":[{"id":1162,"kind":"person","name":"Gold Kelly","position":1,"cik":"0002033333","reported_name":"Gold Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-11T20:24:34.000Z","date":"2025-09-11","kind":"purchase","planned":false,"acquired":true,"shares":6060,"price":1.65,"value":9999.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 11, 2025, the reporting person acquired shares in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement, dated as of September 9, 2025, by and among the Issuer and certain institutional investors and certain directors, employees, and consultants, at a purchase price of $1.65 per share."}],"balance_after":67877,"source":{"system":"sec-edgar","filing":"0002033333-25-000003","document":"wk-form4_1757622271.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033333/000203333325000003/wk-form4_1757622271.xml","form_type":"4"}},{"id":1180320,"issuer":{"id":1161,"kind":"organization","name":"Camp4 Therapeutics Corp","symbol":"CAMP"},"owners":[{"id":1162,"kind":"person","name":"Gold Kelly","position":1,"cik":"0002033333","reported_name":"Gold Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-03T20:07:07.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest in equal monthly installments over a period of four years commencing from the date of grant."}],"balance_after":80000,"derivative":{"exercise_price":3.86,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001628280-25-016482","document":"wk-form4_1743710820.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033333/000162828025016482/wk-form4_1743710820.xml","form_type":"4"}}]}